GE HealthCare Technologies Inc. reaffirmed earnings guidance for the full year 2024. For the year, the company expected organic revenue growth of approximately 4% year-over-year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
81.75 USD | -0.13% | +0.89% | +5.73% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.73% | 37.32B | |
+11.91% | 227B | |
+15.46% | 198B | |
+18.58% | 142B | |
+30.36% | 111B | |
+0.27% | 64.16B | |
+17.74% | 54.1B | |
+5.82% | 51.41B | |
+11.23% | 45.32B | |
+27.16% | 32.13B |
- Stock Market
- Equities
- GEHC Stock
- News GE HealthCare Technologies Inc.
- GE HealthCare Technologies Inc. Reaffirms Earnings Guidance for the Full Year 2024